Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Oct;108(10):1788-98.
doi: 10.1111/add.12266. Epub 2013 Jul 12.

Comparison of behavioral treatment conditions in buprenorphine maintenance

Walter Ling  1 , Maureen Hillhouse, Alfonso Ang, Jessica Jenkins, Jacqueline Fahey
Affiliations
Randomized Controlled Trial

Comparison of behavioral treatment conditions in buprenorphine maintenance

Walter Ling et al. Addiction. 2013 Oct.

Abstract

Background and aims: The Controlled Substances Act requires physicians in the United States to provide or refer to behavioral treatment when treating opioid-dependent individuals with buprenorphine; however, no research has examined the combination of buprenorphine with different types of behavioral treatments. This randomized controlled trial compared the effectiveness of four behavioral treatment conditions provided with buprenorphine and medical management (MM) for the treatment of opioid dependence.

Design: After a 2-week buprenorphine induction/stabilization phase, participants were randomized to one of four behavioral treatment conditions provided for 16 weeks: cognitive behavioral therapy (CBT = 53); contingency management (CM = 49); both CBT and CM (CBT + CM = 49); and no additional behavioral treatment (NT = 51).

Setting: Study activities occurred at an out-patient clinical research center in Los Angeles, California, USA.

Participants: Included were 202 male and female opioid-dependent participants.

Measurements: Primary outcome was opioid use, measured as a proportion of opioid-negative urine results over the number of tests possible. Secondary outcomes include retention, withdrawal symptoms, craving, other drug use and adverse events.

Findings: No group differences in opioid use were found for the behavioral treatment phase (χ2 = 1.25, P = 0.75), for a second medication-only treatment phase, or at weeks 40 and 52 follow-ups. Analyses revealed no differences across groups for any secondary outcome.

Conclusion: There remains no clear evidence that cognitive behavioural therapy and contingency management reduce opiate use when added to buprenorphine and medical management in opiate users seeking treatment.

Keywords: Behavioral treatment; buprenorphine; cognitive behavioral therapy; contingency management; medication management; opiates; opioids.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Consort Flow Diagram. *Analyses for each phase included participants who began the phase;follow-up analyses include those who completed follow-up.
See this image and copyright information in PMC

Comment in

References

    1. Amass L, Kamien JB, Mikulich SK. Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet. Drug Alcohol Depend. 2000;58:143–52. - PubMed
    1. Fiellin DA, Rosenheck RA, Kosten TR. Office-based treatment for opioid dependence: Reaching new patient populations. Am J Psychiatry. 2001;158:1200–04. - PubMed
    1. Fudala PJ, Bridge TP, Herbert S, Chiang CN, Leiderman DB the Buprenorphine/Naloxone Collaborative Study Group. NIDA Research Monograph. US. Vol. 179. Rockville: DHHS/NIH/NIDA; 1998. A multisite efficacy evaluation of a buprenorphine/naloxone product for opioid dependence treatment; p. 105.
    1. Ling W, Wesson DR, Charuvastra C, Klett CJ. A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence. Arch Gen Psychiatry. 1996;53:401–7. - PubMed
    1. Ling W, Charuvastra VC, Collins JF, Batki S, Brown LS, Jr, Kintaudi P, et al. Buprenorphine maintenance treatment of opioid dependence: A multicenter randomized clinical trial. Addiction. 1998;93:475–86. - PubMed

Publication types

MeSH terms